class name | count |
---|---|
rosids | 4 |
asterids | 3 |
class name | count |
---|---|
Rosaceae | 3 |
Apiaceae | 2 |
Asteraceae | 1 |
Salicaceae | 1 |
br08003 Category | # of metabolite |
---|
br08003 Category | KEGG ID | KNApSAcK ID |
---|
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00002766
![]() |
Phenetyl caffeate
|
CHEMBL319244
CHEMBL1397711 |
C055494
|
139 / 92 / 90 | 37 / 20 |
![]() |
C00022586
![]() |
2-Phenylethyl ferulate
|
CHEMBL442022
|
![]() |
|||
C00032180
![]() |
Spiraformin A
|
![]() |
||||
C00032181
![]() |
Spiraformin B
|
![]() |
||||
C00032182
![]() |
Spiraformin C
|
![]() |
||||
C00041758
![]() |
p-Hydroxyphenethyl trans-ferulate
/ p-Hydroxyphenylethyl-trans-ferulate |
CHEMBL481245
|
1 / 0 / 0 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002766 | 1 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00002766 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002766 | 7 / 37 |
P17516 | Aldo-keto reductase family 1 member C4 | Enzyme | C00002766 | 1 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002766 | 4 / 1 |
Q99700 | Ataxin-2 | Unclassified protein | C00002766 | 1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00002766 | 2 / 0 |
O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00002766 | 0 / 0 |
P14618 | Pyruvate kinase PKM | Enzyme | C00002766 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002766 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002766 | 0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00002766 | 2 / 2 |
P08246 | Neutrophil elastase | S1A | C00002766 | 2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00002766 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00002766 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00002766 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00002766 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00002766 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00002766 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00002766 | 2 / 2 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00002766 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00002766 | 11 / 10 |
P37840 | Alpha-synuclein | Unclassified protein | C00002766 | 4 / 2 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00002766 | 3 / 2 |
P00918 | Carbonic anhydrase 2 | Lyase | C00002766 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00002766 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002766 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00002766 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00002766 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00002766 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00002766 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00002766 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00002766 | 0 / 0 |
P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00041758 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00002766 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00002766 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00002766 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002766 | 0 / 1 |
P54132 | Bloom syndrome protein | Enzyme | C00002766 | 1 / 2 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00002766 | 1 / 8 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00002766 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002766 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00002766 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00002766 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00002766 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00002766 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00002766 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00002766 | 1 / 1 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00002766 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00002766 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00002766 | 1 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002766 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002766 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00002766 | 0 / 0 |
P42330 | Aldo-keto reductase family 1 member C3 | Enzyme | C00002766 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00002766 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00002766 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00002766 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00002766 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00002766 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00002766 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00002766 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00002766 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00002766 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00002766 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00002766 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00002766 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00002766 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00002766 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00002766 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002766 | 1 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00002766 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00002766 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00002766 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00002766 | 1 / 1 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002766 | 0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00002766 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002766 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00002766 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00002766 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00002766 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002766 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00002766 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00002766 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00002766 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00002766 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00002766 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00002766 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00002766 | 0 / 0 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00002766 | 2 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00002766 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002766 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00002766 | 2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002766 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002766 | 3 / 3 |
Q04828 | Aldo-keto reductase family 1 member C1 | Enzyme | C00002766 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002766 | 2 / 2 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00002766 | 5 / 2 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002766 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00002766 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00002766 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00002766 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00002766 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00002766 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00002766 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00002766 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00002766 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00002766 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00002766 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00002766 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00002766 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002766 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002766 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002766 | 0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00002766 | 0 / 0 |
P52895 | Aldo-keto reductase family 1 member C2 | Enzyme | C00002766 | 1 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00002766 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002766 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00002766 | 4 / 3 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00002766 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002766 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00002766 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00002766 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00002766 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00002766 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00002766 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00002766 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00002766 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002766 | 0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00002766 | 1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002766 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002766 | 1 / 1 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00002766 | 1 / 0 |
Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | C00002766 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00002766 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002766 | 1 / 2 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002766 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002766 | 1 / 4 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002766 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00002766 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00002766
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00002766
|
9564 | BCAR1, CAS, CAS1, CASS1, CRKAS, P130Cas | breast cancer anti-estrogen resistance 1 |
C00002766
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00002766
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00002766
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00002766
|
891 | CCNB1, CCNB | cyclin B1 |
C00002766
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00002766
|
898 | CCNE1, CCNE | cyclin E1 |
C00002766
|
929 | CD14 | CD14 molecule |
C00002766
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00002766
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00002766
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00002766
|
1053 | CEBPE, C/EBP-epsilon, CRP1 | CCAAT/enhancer binding protein (C/EBP), epsilon |
C00002766
|
1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00002766
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00002766
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00002766
|
3606 | IL18, IGIF, IL-18, IL-1g, IL1F4 | interleukin 18 (interferon-gamma-inducing factor) |
C00002766
|
3552 | IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1 | interleukin 1, alpha |
C00002766
|
3558 | IL2, IL-2, TCGF, lymphokine | interleukin 2 |
C00002766
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00002766
|
3684 | ITGAM, CD11B, CR3A, MAC-1, MAC1A, MO1A, SLEB6 | integrin, alpha M (complement component 3 receptor 3 subunit) |
C00002766
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00002766
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00002766
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00002766
|
4791 | NFKB2, H2TF1, LYT-10, LYT10, NF-kB2, p105, p52 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
C00002766
|
5320 | PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2 | phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) |
C00002766
|
5747 | PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK | protein tyrosine kinase 2 (EC:2.7.10.2) |
C00002766
|
5914 | RARA, NR1B1, RAR | retinoic acid receptor, alpha |
C00002766
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00002766
|
6196 | RPS6KA2, HU-2, MAPKAPK1C, RSK, RSK3, S6K-alpha, S6K-alpha2, p90-RSK3, pp90RSK3 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 (EC:2.7.11.1) |
C00002766
|
7042 | TGFB2, LDS4, TGF-beta2 | transforming growth factor, beta 2 |
C00002766
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00002766
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00002766
|
7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00002766
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00002766
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00002766
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#614279 | 46,xy sex reversal 8; srxy8 |
P17516
P52895 |
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#114500 | Colorectal cancer; crc |
P18054
|
#162800 | Cyclic neutropenia |
P08246
|
#127750 | Dementia, lewy body; dlb |
P37840
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
P18054 |
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 |
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#159900 | Myoclonic dystonia |
P14416
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P37840
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00057 | Parkinson's disease (PD) |
P37840
(related)
|
H00066 | Lewy body dementia (LBD) |
P37840
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D002286 | Carcinoma, Ehrlich Tumor |
C00002766
|
D005910 | Glioma |
C00002766
|
D006331 | Heart Diseases |
C00002766
|
D020925 | Hypoxia-Ischemia, Brain |
C00002766
|
D007414 | Intestinal Neoplasms |
C00002766
|
D007674 | Kidney Diseases |
C00002766
|
D015473 | Leukemia, Promyelocytic, Acute |
C00002766
|
D008107 | Liver Diseases |
C00002766
|
D008113 | Liver Neoplasms |
C00002766
|
D008545 | Melanoma |
C00002766
|
D028361 | Mitochondrial Diseases |
C00002766
|
D009203 | Myocardial Infarction |
C00002766
|
D009336 | Necrosis |
C00002766
|
D009361 | Neoplasm Invasiveness |
C00002766
|
D009362 | Neoplasm Metastasis |
C00002766
|
D009410 | Nerve Degeneration |
C00002766
|
D011041 | Poisoning |
C00002766
|
D011230 | Precancerous Conditions |
C00002766
|
D015427 | Reperfusion Injury |
C00002766
|
D013118 | Spinal Cord Diseases |
C00002766
|